Reframe your treatment experience with the #1 most-prescribed oral medication for advanced basal cell carcinoma.*
Erivedge® (vismodegib) capsule is a prescription medicine used to treat adults with a type of skin cancer, called basal cell carcinoma, that has spread to other parts of the body or that has come back after surgery or that your healthcare provider decides cannot be treated with surgery or radiation.
It is not known if Erivedge is safe and effective in children.
*According to IQVIA real-world prescription data of FDA-approved treatments for aBCC between February 2012 and August 2025.
Model is not an actual patient.
Reframe your treatment experience with the #1 most-prescribed oral medication for advanced basal cell carcinoma.*
Erivedge® (vismodegib) capsule is a prescription medicine used to treat adults with a type of skin cancer, called basal cell carcinoma, that has spread to other parts of the body or that has come back after surgery or that your healthcare provider decides cannot be treated with surgery or radiation.
It is not known if Erivedge is safe and effective in children.
*According to IQVIA real-world prescription data of FDA-approved treatments for aBCC between February 2012 and August 2025.
Model is not an actual patient.
Reframe your treatment experience with the #1 most-prescribed oral medication for advanced basal cell carcinoma.*
Erivedge® (vismodegib) capsule is a prescription medicine used to treat adults with a type of skin cancer, called basal cell carcinoma, that has spread to other parts of the body or that has come back after surgery or that your healthcare provider decides cannot be treated with surgery or radiation.
It is not known if Erivedge is safe and effective in children.
*According to IQVIA real-world prescription data of FDA-approved treatments for advanced basal cell carcinoma between February 2012 and November 2021.
Reframe your treatment experience with the #1 most-prescribed oral medication for advanced basal cell carcinoma.*
Erivedge® (vismodegib) capsule is a prescription medicine used to treat adults with a type of skin cancer, called basal cell carcinoma, that has spread to other parts of the body or that has come back after surgery or that your healthcare provider decides cannot be treated with surgery or radiation.
It is not known if Erivedge is safe and effective in children.
*According to IQVIA real-world prescription data of FDA-approved treatments for advanced basal cell carcinoma between February 2012 and November 2021.
Model is not an actual patient.
Erivedge® (vismodegib) is a prescription medicine designed to treat adults with advanced basal cell carcinoma (BCC) that has spread to other parts of the body, returned after surgery, or cannot be treated with surgery or radiation. ERIVEDGE is not indicated for pediatric patients. It is not known if ERIVEDGE is safe and effective in children.
Erivedge is designed to work by interrupting signals in certain cells of the body that can cause BCC to grow.
Erivedge is administered daily as an oral capsule. It is important to take Erivedge exactly as your doctor tells you.
Common side effects of Erivedge include muscle spasms, hair loss, loss or changes in how things taste, weight loss, tiredness, nausea or vomiting, diarrhea, decreased appetite, constipation, and joint pain. Erivedge can cause serious side effects such as embryo-fetal toxicity, severe skin reactions, and bone growth abnormalities.
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.